1. Home
  2. AVNT vs WVE Comparison

AVNT vs WVE Comparison

Compare AVNT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avient Corporation

AVNT

Avient Corporation

HOLD

Current Price

$32.75

Market Cap

2.9B

Sector

Industrials

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$15.51

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVNT
WVE
Founded
1927
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.0B
IPO Year
1993
2015

Fundamental Metrics

Financial Performance
Metric
AVNT
WVE
Price
$32.75
$15.51
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
$45.67
$29.94
AVG Volume (30 Days)
786.2K
13.9M
Earning Date
02-12-2026
11-10-2025
Dividend Yield
3.38%
N/A
EPS Growth
N/A
N/A
EPS
1.23
N/A
Revenue
$3,246,100,000.00
$109,230,000.00
Revenue This Year
$2.24
N/A
Revenue Next Year
$2.35
$16.00
P/E Ratio
$25.97
N/A
Revenue Growth
1.03
103.75
52 Week Low
$27.48
$5.28
52 Week High
$44.78
$21.73

Technical Indicators

Market Signals
Indicator
AVNT
WVE
Relative Strength Index (RSI) 66.16 53.14
Support Level $31.09 $14.46
Resistance Level $31.82 $18.50
Average True Range (ATR) 0.61 1.37
MACD 0.14 -0.54
Stochastic Oscillator 95.05 18.48

Price Performance

Historical Comparison
AVNT
WVE

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: